Hospital AI Adoption Drives Up Healthcare Costs

Blue Cross Blue Shield (BCBS), a major U.S. health insurer, announced that hospitals' adoption of AI tools has increased medical costs. According to the company's calculations, hospital use of AI resulted in approximately 942 million dollars (about 140 billion yen) in additional healthcare costs over two years. While AI has been expected to contribute to healthcare efficiency, this data suggests it may have had the opposite effect, at least in terms of costs.

AI adoption in the healthcare sector has long been expected to reduce costs through improved diagnostic accuracy and automated workflows. AI tools that assist physicians and help prioritize tests have rapidly spread across hospitals worldwide and have been positioned as a means to simultaneously improve both healthcare quality and efficiency. Against this backdrop, the insurance company's claim that "AI increased healthcare costs" is a development that sparks significant industry discussion.

BCBS points out that hospitals using AI tools increase medical utilization—including hospitalizations and tests—thereby expanding total healthcare spending. One possible mechanism is that AI detects symptoms and testing needs that were previously overlooked, leading to more medical interventions. The fact that such a significant level of additional costs accumulated over just two years represents a substantial financial impact that insurers cannot ignore.

The importance of this issue extends beyond the simple increase in costs. Until now, discussions about AI adoption have centered on "how to improve healthcare," but BCBS's claim places the question "who bears that cost" squarely on the table. In the healthcare industry, where the interests of insurers, hospitals, and patients are complexly intertwined, the very evaluation metrics for AI's effectiveness are now being questioned.

The focus going forward appears to be shifting to the interpretive question of whether the AI-driven increase in healthcare costs represents "overtreatment" or the "discovery of medically necessary care that was previously overlooked." Hospitals use AI with the goal of improving patient care, and it cannot be simply deemed "wasteful" to increase medical spending. From the insurers' perspective, however, increased total payments constitute a direct loss and can motivate reconsideration of AI adoption.

Within the broader trend of AI adoption in healthcare, this discussion may have implications for rule-making. Without established mechanisms for determining who and how validates the cost-effectiveness of AI tools, similar conflicts are likely to repeat across different regions. How insurers, hospitals, and regulatory authorities will work together to establish a framework for evaluating the costs of medical AI has become a critical issue moving forward.